Skip to content

10x Genomics, Inc. TXG Lessee Operating Lease Liability Undiscounted Excess Amount

Lessee Operating Lease Liability Undiscounted Excess Amount at other companies

Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%
Enterprise value$4B+199%
P/S6.9×+4.1×

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s lessee operating lease liability undiscounted excess amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s lessee operating lease liability undiscounted excess amount?
10x Genomics, Inc. (TXG) reported lessee operating lease liability undiscounted excess amount of $17.41M in Q1 2026.
How has 10x Genomics, Inc.'s lessee operating lease liability undiscounted excess amount changed year-over-year?
10x Genomics, Inc.'s lessee operating lease liability undiscounted excess amount increased by 0.0% year-over-year, from $17.41M to $17.41M.